Information about reproducing this article in parts or in its entirety may be found online at: http://bloodjournal.hematologylibrary.org/misc/rights.dtl#repub_requests Information about ordering reprints may be found online at: http://bloodjournal.hematologylibrary.org/misc/rights.dtl#reprints Information about subscriptions and ASH membership may be found online at: http://bloodjournal.hematologylibrary.org/subscriptions/index.dtl
Blood (print ISSN 0006-4971, online ISSN 1528-0020), is published semimonthly by the American Society of Hematology, 1900 M St, NW, Suite 200, Washington DC 20036. Copyright 2007 by The American Society of Hematology; all rights reserved.
B L 00
FEBRUARY, 1960
D
of Splenectomy
Th e Journal
of Hematology
VOL. XV, NO. 2
The
Role
in
the
Management
of Thalassemia
By
CARL
H.
SxIITH,
MARION IRVING
E.
ERLANDSON, ScIlULLAN
GERTRUDE
STERN
ANI)
PROGRESS hemolytic
in
in charmany of
the clinical, hereditary anemia. Treatment urgency for corrective disease in the growth Available determined and that formation strated level of compatible erythropoiesis in
areas of the world beyond those originally designated of populations with susceptil)le individuals. evidence indicates that this disease represents hemolytic it also involves for which there homozygous anemia resulting
in
flO
from
an
problem
accelerated
of red
and that this inadequacy fusions are therefore which red cell production however, iron cessive, compatible entails with splenectomy deposition. When normal
is greater than in other hemolytic anemias.3 Transrequired to support the adequate hemoglobin levels fails to achieve. The need for continuous transfusions, of the must blood activity be producing functioning of children our clinic review.
particularly over a
problems
and hemoglobin
excessive levels exmassive presence Cooleys data are splenectofrom the to 9 years
requirement freedom
becomes are
the who
large have
number attended
severe
available mized.
splenectomized
patients
been obtained
5 months
tile Department of Pediatrics, 1/ic New )crk Ilos;)ital-Corllell Medical Center. This investigation was supported by grants from tise National Institute of Arthritis and Metabolic Diseases, U.S .P.H .S. (RG A-227 (C9), and The Childrens Blood Foundation, Inc. Read in part before the American Society of Hematology. April 26, 1958, Atlantic Gift,, New Jersey. Submitted Apr. 27, 1959; accepted for publication June 3, 19.59.
From 197
198
for tions operation.
SMITH,
ERLANDSON,
STERN
AND
SCHULMAN
whom
are
presplenectomy
summarized Many of in
data
other
were
patients
also been
obtained.
as long as
observa-
following
report,4
these
patients
have
the
subject in
the effect
earlier topics of
:
report.
further
specificalthe need
ly for
with
the
the
hemolytic
patterns, infection.
defect,
cardiac
splenectomy the
transfusions
period, abnormal
PATIENT An the function are trast fore, It of required to can is the of usually important The as given close 1) of of the were was blood current urgent routinely observation facilitated were group and evaluation basic disease. for effectively to severely hemoglobin be also made that of the Patients thalassemia without maintain affected effects with fall transfusions, hemoglobin patients, ranging clinically. the in to of by provided had hence 49 the of
MATERIAL splenectomy the into levels those from hemoglobin of our of on previously were not blood clinic, higher the a 58 routine been establishment 7.4 homozygous two and the in to level for will levels.
AND must
MEl-lions take disease into in if multiple with intermediate Gm./100 which levels lower with to ml. blood of over-all homozygous out-patient nine to at the prescribed hospital remaining only hemoglobin account whom the
the both
intermediate supplements
variability parents if of In
heterozygous
classifications: severe the 9.9 for minimal lead children of basis. admitted commensurate
centrations
taken than
into in!. if
Gm./100
a special The
maintained
RESULTS
PreIn patients
and
our
Postsplenectorny
earlier study
was span
in
with
an
intact
method
in this advancing
chromium
study age.
as a
erythrocytes
life
span subjects
of normal show
red
cells the
in the injection
circells 26 in
in normal
tagged days.56
In the present of the half-life employing exceptions survival children, cells than
age of the patient and the group. Two of the younger a shorter survival of donor
of normal donor cells noted in the A. Y. and V. P. (cases 3 and 4) do the older patients A. C. and
SPLENECTOMY
AND
THALASSEMIA
MANAGEMENT
199
Table
1 ..-Severe
Cooleys
Anemia
Living Dead
Total Splenecto
no.
of
patients:
58 29
44 16
14 13
mized:
00
90
80
70
I.,
z
60
w
ILl
50
a.
g
0
!?
40
30
20
I0
20 TIME-DAYS
25
30
35
Fig. 1.-Cooleys anemia. Cr51 RBC survival studies (donor cells) on nonsplenectomized patients. Note the shortened survival of normal donor red cells. There is no uniform relationship between the age of the patient and life-span of the red cells,although the longest red cell survival occurred in J. V.. P/2 years old, and the shortest in M. M., 18 years old. F. P. (cases the youngest whereas the in this early could \Vith time
adolescence-in
8).
the
other
hand,
in donor in M.
J.
group. in life
extracorpuscular
any
hemolytic not
therefore
of for its
on the
be manifest defect.
factor
in marked
number
degree
transfusions causation.
to be
of in
shortened eventually
survival be-
donor
1 to 6. extent, thrombocytopenia,
observed
200
SMITH,
ERLANDSON,
STERN
AND SCHULMAN
00
00
90
90
80
80
70
70
z
z
4 ILl Ui
60
60
50
50
a.
0
U)
40
40 30 20
I0
30
20
I0
20
25 TIME-DAYS
30
35
40
45
50
studies
showing
normal
donor
of our in 1)
ranged
cases
to
prior
to
splenectomy,
may
be
attributed except
a hyperactive
spleen2#{176} or
suppression
It patient life
are as
will
the with
from
postsplenectomy a red
of lower as perhaps normal
J.
above range
F. the
cell
survival
suggests
chromium
in the the
others of
upper
normal anemia,
limit
is
extensive
refractory
that most of these values that 26 to 32 days given data would warrant, or
anemias, survival of
is
patients in this
splenectomy.
20 years; fig. 2) This reversal confirms the evidence disease and provides
life an
normal
this
for one
hemolytic beneficial
explanation
and these
Postsplenectomy patients
of accelerated transfusion requirements to maintain an adequate hemolevel necessitates consideration of splenectomy. \Vhile efforts are made immediate presplenectomy so as to defer period splenectom, to the vary blood the number and size of transfusion requirement nevertheless
the
the
SPLENECTOMY
AND
THALASSEMIA
MANAGEMENT
becomes
so
extreme
that
the
decision
The increasing need for transfusions before splenectomy and the sharp reduction after this procedure is obvious in this group of patients. The striking diminution in the number of transfusions following splenectomy is the fused that and result transfusions hemoglobin of seveial possess synthesis. factors, a one of which In is the addition longer it has endogenous is clearly normally transfusions and hemoglobin of the result. of growth by patient. and survival been of transerythrocytes, as mentioned above. demonstrated in
splenectomy
maximally
function with
is
restored the
accordance
amounts of both fetal and adult types It is possible that in later adolescence metabolic removing
sistence on
permit and
adequate inhibitory
at lower
of endogenous
or trauma supervenes. It is to be expected, hemolytic of normal therefore, After blood donor greater an initial requirements span
extracorpuscular
in an
increased
and example.
P. (fig. of life as to
transfusions, in
splenectomy. is reflected
of
The increase in half-life of donor blood a lessened need for blood supplements.
amounts the it
of packed red cells expressed in three month periods from disease until splenectomy with the three years following is apparent that less blood
was required
to gain to
at
as good and at times improved hemoglobin Another feature worthy of note in this current
being
with with
which of the
of an organ
A quantitative
transfusion
requirements
in terms of milliliters of packed cells was made in 13 children for one year preceding splenectomy and for the subsequent postoperative period (fig. 4). The preoperative period of one year was chosen as a basis for comparison because it was associated with a progressive demand for the administration of blood.
single transfusions
T.
transfusion
P.
in
is still
for
in the first year of observation and study purposes in the first postoperative months the this
first
R.
a 10
the
67 in
that
Transfusion year to
requirements determine
compiled
postsplenectomy
any relationship lesser amounts in in those the the of following first the later
202
SIITII,
ERLANDSON,
STERN
AND SCHULMAN
JI?J
(9
1=J::
,-.---
;
.-,?
,
PAr/ENT
C/)
1/2 10
/4 days i 20 i
-
r
-
1/2:34
11
---- - 20
days
i-
bYS-l0
_l
30
0 0
h:
-
1000
_______
SPLENECTOMY
AGE -YEARS
Fig. 3.-Cr5 donor case (V. P.) in which following splenectomy gain in weight is also instance to maintain Effect The splenectomy intracorpuscular the principal is the rium. level The improvement preoperative
RBC survival studies pre- and postsplenectomy of a typical the half-life of donor erythrocytes rose from 14 to 34 days with a lessened need for transfusions. The postsplenectomy apparent.
was
noted hemoglobin
with
respect levels.
to reduced
blood
requirements
on the course be of
Ba.sic these as
Disease patients
fringe
indicates
benefits,
that
for
the the
results fundamental
of of
regarded
patient destruction
of red blood cells and total hemoglobin has been the patients own chromium-labeled red cells in permitting the measurement of the longevity of environment. involve the The a consideration calculations of the of the mean rates cell of both life, which
by reinjecting circulation, thus in their natural and production from the for is derived a study of of the need
chromium half-life of the patients own cells.3 Only a limited number of patients lend themselves to life span of their red cells in their own circulation because
multiple sample of transfusions in most patients patients after
with two
severe
of
the
tagged
cells
blood would
of such necessarily
reinjection
contain
populations
SPLENECTOMY
. flIHiIhf1iri
QI
AND
TIIALASSEMIA
MANAGEMENT
203
YEAR
DTOTAL
U)
52OO1flIrftIftjftIftIftIjjftIr.jlIjI.fJ
FG. 60 mos. J.P 71 mos. V.P. 39 mos. AD. 56 mos P.C. 21 mos. J.N. 76 mos. D.B. 14 mos J.B. 8 mos R P. 67 mos
T.P.
S.S
MG.
60 mos
DE
71 mos
5 99 mos. mos
concentrations and average monthly transfusion requiremilliliters of packed red cells in the pre- and postsplenectomy periods. Note that reduced blood supplements were needed to maintain preoperative hemoglobin levels. They were no different in the first postoperative year (dotted column) from later years (open column).
ments in terms of
Fig.
4.-Hemoglobin
and
the
A group available
with
at had
equilibrium of their
been
chromium
splenectomized.
of chromium-tagged the normal survival the two splenectomized own cells group.
red cells ranged of 26 to 32 days. patients that falls Therefore, over defect within the A. D. the red
and R. P. reveal a chromium range of the severely affected cell survival intact spleens, unaltered.
upon
of their intermediate
small
a
effects
larger
be
investigated
postsplenectomy.
The
Factors
of Growth
and
and
ment
remain
6 and weight at
7). at
The time
children
their
with grow
anemia
are a marked
of
average of retardation,
height 8 to 10 so that
birth. They
until about
the age
which attain a
growth
204
SMITh,
ERLANDSON,
STERN
AND
SCHULMAN
00
(9
z
4 Ui Ui
a.
0 I0
U)
20
TI ME-DAYS
=S EVERE COOLEYS ANEMIA COOLEYS AGE (yrs) Hemoglobin (gm./lOOml.) ANEMIA Fetal Hemoglobin % CR51
TI/2l
(doys)
12.5 11.5 16.0 6.5
splenectomized
AS.
9.4
59.7
19.5
Fig. 5.-Cr5 RBC survival studies of homozygous Cooleys anemia (patients cells in patients circulation). The severely affected and intermediate (homozygous) patients as well as the two who were spenectomized reveal equal intracorpuscular defects, as indicated by the shortened survival of their own red cells. Note also the large amounts of fetal hemoglobin and the lack of correlation with severity of the
disease.
very
short final
height.
population,
Secondary
sexual
characteristics
develop
later
than series
normal
Normal after
are
rare
and this
in our
several
months
Whether
liver pitttitary,
dysfunction, thyroid
Cardiac In
one
idiopathic of unknown
to
hemochromatosis, cause.
splenectomy. from
cardiac
failure
complicationbo.13
had above.
been
tion and
of heart anemia to
12 to 27 years
the lives before antibiotics transfusions
for increased
W7hile heart
prolong
nevertheless
SPLENECTOMY
AND
THALASSEMIA
MANAGEMENT
205 or otherwise, irreverspatients. Splenectomy of Cooleys of the basic failure. from four premature flutter, one of our
represents It does
process
The
months beats
duration
to one
of life followed
from The by
initially episodes
auricular cases,
fibrillation,
ventricular
contractions4
of ventricular
Pen card itLs One of the unusual acute pericarditis had undergone
findings
of
features in eight
in this patients
seven variously
complex
splenectom.
corresponded
trocardiographic
designated
as Cooleys
as that
acute
benign,
a benign
elecbeen
as
anemia
variety
be
solely in and
involved
a our another clinical patients
in
the
etiology
so
Sporadic unsuccessful.
attempts All of
benign,
a moderate
this
also of
cleared the
physical
for
the
susceptibility
is
this
type
of
proven
Infection
valueless,
and
treatment
consists
of symptomatic
relief.
Increasing previously in
of
of case reports547 have dealing with postsplenectomy additional anemia one cases of overwhelming have been year previously
further documented those susceptibility to infection and fatal infection child 5 years 48 hours with in One within
children.
age
patients
with Cooleys had a splenectomy sepsis. previously and Two children in whom had patients with
pneuniococcus
had a splenectomy four within a period of nine also recently been obinfections
hereditary
serious
meningitis
postsplenectomy the one majority former year of and or less, therapy and seven cases
occurred.
spherocytosis. adrenal insuf-
Pneumococcic
acute
hyperpyrexia
in the Since in
latter, the
it has for
years.
206
SMITH,
ERLANDSON,
STERN
AND
SCHULMAN
C V C C
(I)
C C
0.
.C :ff
______
0
I
0 1)
z
I
t-
_J H
.
.
..j h
___
.:
Ii
IV
.
.:#{149}
..f
II!
4
0
I 0
\c_-.
d
cots
.
SPLENECTOMY
AND
THALASSEMIA
MANACEMENT
207
COMMENTS
there
eliminates donor
is
abundant
a hemolytic
evidence
component
that
splenectomy
in
severe
cells
patients
probably
own
cells,419 remains
cells may
which shortens the survival destruction of the patients defective The intensity of the destruction of
minimally reduced
,
in
the the
splenectom-
ized
made pre-
patients
until and
( A.
more
D.
and
R.
P.,
fig.
are
but
no
out
absolute
in
can patients
extended
studies periods.
carried
postsplenectomy
data of re-establish
the the
longer influenced by in the splenectomized levels because accelerated anemia the need
is
adequate
in
hemoglobin
rate of red cell destruction. than in any other congenital of transfusion therapy in the
proper selection of patients increased, condition.
A critical
for splenectomy. is clearly
problem
Cooleys
anemia
the
In
the
when
severely
transfusion and to differentiate concurrent
affected by
individual
requirements
the
are
need
persistently
for
clinical
splenectomy
indicated at times
by massive It is difficult
puscular red and
splenomegaly, defect
deterioration
between
the
of the acquisition
of an
of
extracor-
hemolytic
or an useful. into
with for
exaggerated
related to
hypoplastic
a minor
frequently
infection.
tests an
patient criteria
with
the
use
chromium
provides the
un-
splenectomy
necessary.2#{176} Additional
benefits
from
splenectomy
accruing
to the
patient
may stem from the greater oxygen to the tissues than of patients by with
anemia
Cooleys
to
thinned
C3oleys
splenectomy
be physically active be explained on this basis. effectiveness of splenectomy reduced postoperative The disease the well function slowing being to and delay of of age permitting
older
age
explained
splenectomy
growth
equilibrium
erythropoietic
can
without splenectomy
supplementation until
transfusions. it is fre-
preference
SMITh,
ERLANDSON,
STERN
AND
SCHULMAN
the
in the papers of
for
the on
compiled in
sible the
infection
modification
children
normal anemia.
immunologic
splenectomy
functions
following
increased susceptibility this disease indicate against invading now in progress phagocytic the spleen. numbers children small.
the immunologic defenses residing in this organ are unimpaired. In the course cf an investigation with the causation of postsplenectomy infections, been found normal regardless of the presence of l)e emphasized ies in Cooleys severe supervision treatment Transfusions and that in comparison with the increasing anemia and in other dyscrasias in overwhelming for several years may be immediately which are an for the infections is relatively in the support postoperatively instituted required increased normal to
It should
of splenectomthe incidence
Nevertheless,
close
is essential so that appropriate event of an infection. adequate hemoglobin accumulates 1 mg. levels
in
pro(luce simultaneously the tissues and, except cannot deposits sites ticularly
daily,
leave the body except by bleeding. in normal storage depots increase assume the noticeable in function in of patients iron storage. receiving by the iron to
in
Under such conditions, hemosiderin greatly, and in addition accessory Another minimal gastrointestinal is stored in fibrotic liver areas and source of tissue is tract and cardiac This to the hypoxia, factors
does usually spleen
pariniron as
transfusions, the
The
conversion occurs
characterizing pancreas.
on other in tissues.
anemia,22 may to
represent
the
the
production
inevitable
of
hemochromatosis.
irreversible
Removal
heart
of
the
disease
progression
in the The
with
young failure
Ccoleys
Inales trast,
female
with idicpathic
has
adult. to mature normally and menstruate deprives the female patient anemia of the opportunity to unload iron; thus both females and this disorder become susceptible to hemochromatosis. In conhemochromatosis
already achieved sexual
occurs
maturity
predominantly
at an age
in
when
males the of
has
since
the
toms stantial
cessfully
of this
disease of of
to in
appear pregnancy,
idiopathic
and
is thus lactation
hemochromatosis In
capable and
Cooleys
amounts
achieved
phlebotomies.1323
for measure.
maintaining The
of excretion iron
adequate intravenous
but is
hemoglobin injection
impractical
levels of chelating
in
precludes agents
of
the increases
conditions
use
treatment
which
massive
iron
overload
Until
specific
treatment
the failure.
SPLENECTOMY
AND
THALASSEMIA
MANAGEMENT
fective is the
therapeutic discovery
measures of a means
are to rid
of excessive
SUMMARY
of were
58 aspects.
children reviewed
eliminates
severe several
Cooleys of the
anemia, more
half important
of
them clinical
the
accelerated
destruction
of normal
represents of normal
improved, own significantly
increased of transas
of defect
blood
hemoglobin
was
required
levels.
maintain
of basic
least
good,
is
survival
erythrocytes
suggest
altered
this
operative
procedure.
While
in
the retarded.
normal
patients
individuals
well
and
being, sexual
normal
Secondary
are
but
one
been in
to
enlargement,
heavy respect
deposition to and of an
in
of
similal
iron in the
in
the in
this prevention
incidence congestive
method
most
serious
management heart
of
depend
infection
the
by which the heart The increased susceptibility with severe Cooleys anemia
inherent in
be made that
indicates
intact
the
despite
normal the
immunologic stress of
hemolytic
the process.
spleen
SUMMARIO
IN
INTERLINGUA
Esseva clinic
passate
in
revista, le casos
ab
de
plures
del
plus
importante
punctos
de sever
vista de
e hematologic,
58 patientes
pediatric
con
grados
anemia de Cooley. Un medietate (lel patientes haheva Splenectomia elimina le mechanismo extracorpuscular pro le accelerate destruction de normal erythrocytos circulation le prolongate reduction pro tiones
basic intervention
le
del del
Isto de
representa normal
Minus
nivellos del patiente
significativemente
sanguine de mesme
esseva
mantener del
defecto
meliorate
alterate
hemoglobina.
superviventia
hemolytic chirurgic.
erythrocytos
Ic
SMITH,
ERLANDSON,
STERN
AND
SCHULMAN
que
transfusiones
e splenectomia
del Le
patiente,
que istes,
e
normal a
Disfallimento habeva
refractori complicationes
in 10 del
arrhythmias
exdisdel
spenectomia.
durante
gruppo
char-
morte
del
cardiac
usualmente probabilemente
le secunde
decennio
vita.
Le relationate
a! massive
deposiinplus de de
sti
tion de ferro in le myocardio e es simile in iste respecto a un comparabile cidentia de complicationes cardiac in hemochromatosis idiopathic. Un del serie problemas in le tractamento de anemia de Cooley es Ic prevention congestive
un efficace
disfallimento
methodo per
cardiac.
que
Su le corde de de inherente
va esser
depender inducite
del
discoperta
de-
subjicite que Ic
in Ic splen
in despecto
hemolytic.
REFERENCES
1.
P.,
C.
A.:
Ery-
sodium
life health orders. 8. Necheles,
LeRoy, chromate
chromate
to
evaluate
span and T.
of Am.J.M.Sc. F.,
the certain
red 228:40,
blood hematologic
12:64,
R. C. in
2.
1954. I.
of
Haemoglobin
Weinstein,
Radioactive
M.,
and
In Vitro
1959. Schulman, C. H.: and
thalassemia.
C.
for
V.:
the
cells.
sodium
study
3.
Erlandson,
Stem, of I. 9.
of
cells.
red
I.
C.,
Rates of
and
of erythrocytes
radioactive
chromate
congenital
syndromes.
Smith,
E., terranean
Ando,
and
(Cooleys)
I., Studies
R. MediI. 10.
suppression transfusions. Bothwell, T., Am. 11. Levin, in 12. Lewis, 544, 45:277, H. and Heart E. B., 1953. P.: T. duPreez,
B.,
Alpev, cardiac
Clinical
of ence
splenectomy,
with
hemoglobin
complications
fetal
10:582,
P. L.,
J.
and
Blood 5. Mollison,
of red
1955.
and
The Heart
heart
Veall, 51Cr as
N.: a
The label
use for
hemochromatosis. Cardiac
J.
in
the cells. E.
isotope
Brit.J.Haemat.
6.
Donohue,
D. M.,
R., and
Motulsky,
hemochromatosis.
lett, of
1954.
S. C., and Finch, A. Iron C. hemochromatosis, disease. hemochromatosis. 1955. Medicine
C. A.: The
tag. and
13.
Finch, pathic
as a red-cell
J.Haemat. 7. Read,
ner, H.:
1:249,
Wilson, The
34:
SPLENECTOMY
AND
THALASSEMIA
MANAGEMENT
211
21. Valtis,
oxygen
14.
Goldberg,
C., Heart siderosis preparation.
H. P., Engle,
I., and C. in D.: C.: infancy. Congenital and chronic Hereditary disease associated
M. A.,
Smith, with anemia.
D.
J., and
of red-cell
Baikie,
A.
G.:
on
The
the
Schulman,
thickness
dissociation
1:146, and Wyatt, pigmentary anemia. 1953. P. NI.: removal repeated (New T. M., The with of Series) Coghill,
curve
1955.
of
blood.
J.,
of
J. P.:
Developin
15.
spherocy50:446, spherocytosis
cirrhosis A.M.A.Arch.Path.
J.Pediat.
55:423,
23. NicAllen, Lubran,
chromatosis
16.
Burman, in 335,
N.
F., reference
and
infancy. 1958. C.
Arch.Dis.Childhood. C.: in H., Infection infants and 1958. M. C.: in E., Hazard following children.
33:
of haemothe body
17.
Huntley, splenectomy
to by
the
Am.J.Dis.Child. 18. Smith, man, severe infants 390, 19. Lichtman, man, j.: F., Studies C. I., and 1957. H. C., on and infections
95:477,
Erlandson, Stern, children. Watson, V.,
J.,
disodium
EDTA
trans-
fusion
Am.J.Clin.Path.
25:266,
25. \Vishinsky,
J.,
1. in
FeldAn
T., Miller,
Prevost, M. acid
Ginsberg,
E.
the in
Ni., Burgen,
mobilization a case of
B., and
J.:
in iron
Ethylenediaminetetraacetic
extra
semia
corpuscular major. 2.
and
removal
1953.
of
hemochromatosis. 42:550,
J.Lab.
& Clin.Med. NlcElfresh, Akabane, ism infant Pediat. occurring with 47:347, A. T.:
E.,
J.
R.,
and
hypersplenseven-month-old major.
J.
1955.